[Off label uses of tigecycline].
Les utilisations hors-autorisation de mise sur le marché de la tigécycline.
Hors-AMM
Indication
Off-label use
Pharmacocinétique
Pharmacodynamic activity
Pharmacodynamique
Pharmacokinetic characteristics
Therapeutic indication
Tigecycline
Tigécycline
Journal
Annales pharmaceutiques francaises
ISSN: 0003-4509
Titre abrégé: Ann Pharm Fr
Pays: France
ID NLM: 2985176R
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
received:
15
04
2020
revised:
05
10
2020
accepted:
13
10
2020
pubmed:
9
12
2020
medline:
26
10
2021
entrez:
8
12
2020
Statut:
ppublish
Résumé
Tigecycline is a relatively new antibiotic that have very limited valid indications. When no other alternative is available, this drug is widely used off label with promising results. The objective of this study is to summarize the different off label uses of tigecycline so that we can decide when and how to prescribe it in the absence of guidelines. This study a revue of the literature collecting all the articles concerning the off label uses of tigecycline. Tigecycline was widely prescribed, off label, to treat infections with controversial results. Randomised clinical trials were conducted to evaluate its use to treat pneumonia. The results for this indication have a respectable level of evidence. For the other indications, the data collected was insufficient to support tigecycline prescription. In fact, different protocols were used which makes it hard to evaluate the efficacy and to conclude to the best treatment regimen. A tendency to prescribe high doses of the molecule was noted in different studies. When prescribed off label, tigecycline prescriptions were associated with a higher mortality and incidence of side effects. The tigecycline remains a valid option for the treatment of infections dues to multi-resistant bacteria especially when other alternatives are scarce or in cases of renal failure.
Identifiants
pubmed: 33289663
pii: S0003-4509(20)30126-7
doi: 10.1016/j.pharma.2020.10.010
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Tigecycline
70JE2N95KR
Types de publication
Journal Article
Review
Langues
fre
Sous-ensembles de citation
IM
Pagination
244-254Informations de copyright
Copyright © 2020 Académie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights reserved.